The Society of Surgical Oncology, inc.
The American Society of Breast Surgeons.
Annals of Surgical Oncology

Log in | Register

Online first

FBXO50 Enhances the Malignant Behavior of Gastric Cancer Cells

Takashi Miwa MD, Mitsuro Kanda MD, PhD, FACS, Haruyoshi Tanaka MD, Chie Tanaka MD, PhD, Daisuke Kobayashi MD, PhD, Shinichi Umeda MD, Naoki Iwata MD, PhD, Masamichi Hayashi MD, PhD, Suguru Yamada MD, PhD, FACS, Tsutomu Fujii MD, PhD, FACS, Michitaka Fujiwara MD, PhD, Yasuhiro Kodera MD, PhD, FACS
Translational Research and Biomarkers
View abstract | View full article HTML | View full PDF

Increased Grade in Neuroendocrine Tumor Metastases Negatively Impacts Survival

Kendall J. Keck MD, Allen Choi BS, Jessica E. Maxwell MD, MBA, Guiying Li MD, Thomas M. O’Dorisio MD, Patrick Breheny PhD, Andrew M. Bellizzi MD, James R. Howe MD
Endocrine Tumors
View abstract | View full article HTML | View full PDF

Induction Chemotherapy Followed by Resection or Irreversible Electroporation in Locally Advanced Pancreatic Cancer (IMPALA): A Prospective Cohort Study

Jantien A. Vogel MD, MSc, Steffi J. Rombouts MD, Thijs de Rooij MSc, Otto M. van Delden MD, PhD, Prof, Marcel G. Dijkgraaf MSc, PhD, Thomas M. van Gulik MD, PhD, Prof, Jeanin E. van Hooft MD, PhD, MBA, Hanneke W. van Laarhoven MD, PhD, Prof, Robert C. Martin MD, PhD, Prof, Annuska Schoorlemmer MSc, Johanna W. Wilmink MD, PhD, Krijn P. van Lienden MD, PhD, Olivier R. Busch MD, PhD, Prof, Marc G. Be
Pancreatic Tumors
View abstract | View full article HTML | View full PDF

Micro-RNA-130a-3p Regulates Gemcitabine Resistance via PPARG in Cholangiocarcinoma

Kei Asukai MD, Koichi Kawamoto MD, PhD, Hidetoshi Eguchi MD, PhD, Masamitsu Konno PhD, Ayumu Asai PhD, Yoshifumi Iwagami MD, PhD, Daisaku Yamada MD, PhD, Tadafumi Asaoka MD, PhD, Takehiro Noda MD, PhD, Hiroshi Wada MD, PhD, Kunihito Gotoh MD, PhD, Naohiro Nishida MD, PhD, Taroh Satoh MD, PhD, Yuichiro Doki MD, PhD, Masaki Mori MD, PhD, FACS, Hideshi Ishii MD, PhD
Hepatobiliary Tumors
View abstract | View full article HTML | View full PDF

Progression to T1 High Grade (T1HG) from a Lower Stage/Grade is Associated with Poorer Survival Outcomes than Initial Diagnosis with T1HG Bladder Cancer

Jung Kwon Kim MD, Chang Wook Jeong MD, PhD, Cheol Kwak MD, PhD, Hyun Hoe Kim MD, PhD, Ja Hyeon Ku MD, PhD
Urologic Oncology
View abstract | View full article HTML | View full PDF

Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study

C. Bisschop MD, T. H. van Dijk MD, J. C. Beukema MD, R. L. H. Jansen MD, PhD, H. Gelderblom MD, PhD, K. P. de Jong MD, PhD, H. J. T. Rutten MD, PhD, C. J. H. van de Velde MD, PhD, T. Wiggers MD, PhD, K. Havenga MD, PhD, G. A. P. Hospers MD, PhD
Gastrointestinal Oncology
View abstract | View full article HTML | View full PDF | Open choice

Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy

Oriana A. Petruolo MD, Melissa Pilewskie MD, Sujata Patil PhD, Andrea V. Barrio MD, Michelle Stempel MPH, Hannah Y. Wen MD, PhD, Monica Morrow MD
Breast Oncology
View abstract | View full article HTML | View full PDF

The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer

Faina Nakhlis MD, Meredith M. Regan ScD, Laura E. Warren MD, Jennifer R. Bellon MD, Judith Hirshfield-Bartek RN, Margaret M. Duggan MD, Laura S. Dominici MD, Mehra Golshan MD, Heather A. Jacene MD, Eren D. Yeh MD, Erin E. Mullaney RN, Beth Overmoyer MD
Breast Oncology
View abstract | View full article HTML | View full PDF

Trends in Sexual Function After Breast Cancer Surgery

Lauren F. Cornell MD, Dawn M. Mussallem MD, Tammeza C. Gibson PA-C, Nancy N. Diehl BS, Sanjay P. Bagaria MD, Sarah A. McLaughlin MD
Breast Oncology
View abstract | View full article HTML | View full PDF

Model to Predict Cause-Specific Mortality in Patients with Head and Neck Adenoid Cystic Carcinoma: A Competing Risk Analysis

Matin Imanguli MD, DDS, Baran D. Sumer MD
Head and Neck Oncology
View abstract | View full article HTML | View full PDF